Effect of device and formulation on delivery of budesonide suspensions by nebulizers Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
Aerosol delivery Source: Annual Congress 2013 –PG4 How to build an experimental animal lung lab Year: 2013
Comparison of aerosol delivery from two inhaler technique-guidance devices. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
The generation of monodisperse pharmacological aerosols using a spinning-top aerosol generator (STAG) Source: Eur Respir J 2005; 26: Suppl. 49, 125s Year: 2005
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung Source: Annual Congress 2009 - New drugs for airways disease Year: 2009
A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006
Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology Source: Annual Congress 2009 - Respiratory disorders of the newborn Year: 2009
Delivery of a suspension corticosteroid formulation by small volume nebulizers: a comparative bench study Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Aerosolization of nanoparticle suspensions in ethanol using Mystic™ drug delivery technology Source: Eur Respir J 2002; 20: Suppl. 38, 541s Year: 2002
A submicron suspension of budesonide improves the mass of ICS delivered during early nebulization Source: Eur Respir J 2006; 28: Suppl. 50, 712s Year: 2006
Electrohydrodynamic atomization of drug solutions for inhalation purposes Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001
Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser Source: Eur Respir J 2003; 22: Suppl. 45, 471s Year: 2003
Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
Determination of tissue concentrations of metabolites in surgical preparations following inhalation of beclomethasone-dipropionate using conventional and extrafine aerosols Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003